NEW YORK, Nov 22 - Applied Biosystems has sold its next-generation MALDI TOF/TOF mass spectrometers and its new ICAT reagents to Geneva Proteomics through an early access agreement, Applied Biosystems announced Wednesday.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.